763 related articles for article (PubMed ID: 8751438)
1. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.
Yan SD; Chen X; Fu J; Chen M; Zhu H; Roher A; Slattery T; Zhao L; Nagashima M; Morser J; Migheli A; Nawroth P; Stern D; Schmidt AM
Nature; 1996 Aug; 382(6593):685-91. PubMed ID: 8751438
[TBL] [Abstract][Full Text] [Related]
2. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM
Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173
[TBL] [Abstract][Full Text] [Related]
3. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD
Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119
[TBL] [Abstract][Full Text] [Related]
4. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG
Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397
[TBL] [Abstract][Full Text] [Related]
5. Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE).
Onyango IG; Tuttle JB; Bennett JP
Mol Cell Neurosci; 2005 Jun; 29(2):333-43. PubMed ID: 15911356
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus.
Valente T; Gella A; Fernàndez-Busquets X; Unzeta M; Durany N
Neurobiol Dis; 2010 Jan; 37(1):67-76. PubMed ID: 19778613
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.
Srikanth V; Maczurek A; Phan T; Steele M; Westcott B; Juskiw D; Münch G
Neurobiol Aging; 2011 May; 32(5):763-77. PubMed ID: 19464758
[TBL] [Abstract][Full Text] [Related]
8. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.
Varadarajan S; Yatin S; Aksenova M; Butterfield DA
J Struct Biol; 2000 Jun; 130(2-3):184-208. PubMed ID: 10940225
[TBL] [Abstract][Full Text] [Related]
9. New insights into the neuropathology and cell biology of Alzheimer's disease.
Weldon DT; Maggio JE; Mantyh PW
Geriatrics; 1997 Sep; 52 Suppl 2():S13-6. PubMed ID: 9307579
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
11. Beta amyloid toxicity does not require RAGE protein.
Liu Y; Dargusch R; Schubert D
Biochem Biophys Res Commun; 1997 Aug; 237(1):37-40. PubMed ID: 9266825
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease.
Pedersen WA; McCullers D; Culmsee C; Haughey NJ; Herman JP; Mattson MP
Neurobiol Dis; 2001 Jun; 8(3):492-503. PubMed ID: 11442356
[TBL] [Abstract][Full Text] [Related]
13. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils.
El Khoury J; Hickman SE; Thomas CA; Cao L; Silverstein SC; Loike JD
Nature; 1996 Aug; 382(6593):716-9. PubMed ID: 8751442
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
Roy S; Rauk A
Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
[TBL] [Abstract][Full Text] [Related]
15. S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses.
Businaro R; Leone S; Fabrizi C; Sorci G; Donato R; Lauro GM; Fumagalli L
J Neurosci Res; 2006 Apr; 83(5):897-906. PubMed ID: 16477616
[TBL] [Abstract][Full Text] [Related]
16. CD36 overexpression in human brain correlates with beta-amyloid deposition but not with Alzheimer's disease.
Ricciarelli R; D'Abramo C; Zingg JM; Giliberto L; Markesbery W; Azzi A; Marinari UM; Pronzato MA; Tabaton M
Free Radic Biol Med; 2004 Apr; 36(8):1018-24. PubMed ID: 15059642
[TBL] [Abstract][Full Text] [Related]
17. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Abdul HM; Calabrese V; Calvani M; Butterfield DA
J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
[TBL] [Abstract][Full Text] [Related]
19. Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier.
Li M; Shang DS; Zhao WD; Tian L; Li B; Fang WG; Zhu L; Man SM; Chen YH
J Immunol; 2009 May; 182(9):5778-88. PubMed ID: 19380826
[TBL] [Abstract][Full Text] [Related]
20. Expression of the receptor for advanced glycation end products in Huntington's disease caudate nucleus.
Ma L; Nicholson LF
Brain Res; 2004 Aug; 1018(1):10-7. PubMed ID: 15262199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
